NCT05571059Phase 2Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Study sponsor: Cumberland Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2028-01Estimated
Enrollment · participants128Estimated
Source updated2026-09-02Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date changed

− Before

Jan 2027

+ After

Jan 2028

Check registry source

· 1 field changed

Primary completion date changed

− Before

Jan 2026

+ After

Jan 2027

Check registry source